ENP
Entropy Neurodynamics Ltd
$0.0370
▲ +2.78%
Market cap
$60M
Turnover
$51,720
Last price
$0.0370
Day change
+2.78%
Announcements
19
Range, past year
Open 0.033 · Low 0.025 · Now 0.037 · High 0.043
Open ENP in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
ENP momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
37/100
Wyckoff phase
Distribution39d
Trend stage
Distribution
1 Day
+2.8%
1 Week
-2.6%
1 Month
-9.8%
RSI
42
Avg daily range
4.3%
Entropy Neurodynamics Ltd scores 37 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Distribution.
On the Wyckoff cycle it sits in Distribution, where it has been for 39 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- Thin liquidity
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsENP announcements
Recent price-sensitive releases.
- 2026-10-07 TRP-8803 60-Minute Infusion Achieved in Phase 2 BED Study Progress Report
- 2026-09-14 All Patients Improve, 50% Achieve 12-Week BED Remission Progress Report
- 2026-08-28 Appendix 4E and 2026 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-08-26 Entropy Advances TRP-8803 to US Phase 2 in Depression Web Cast | Trading Halt Lifted | Progress Report
- 2026-08-24 Trading Halt Trading Halt
- 2026-08-19 TRP 8803 manufacturing secured for Phase 2/3 advancement Progress Report
- 2026-08-04 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation Trading Halt Lifted | Progress Report
More Health Care stocks
Most traded in the same sector.